Seliger B - Search Results

1

TAP off--tumors on.

Seliger B, Maeurer MJ, Ferrone S. Seliger B, et al. Immunol Today. 1997 Jun;18(6):292-9. doi: 10.1016/s0167-5699(97)01052-9. Immunol Today. 1997. PMID: 9190116 Review. No abstract available.

2

Cellular immune response to human renal-cell carcinomas: definition of a common antigen recognized by HLA-A2-restricted cytotoxic T-lymphocyte (CTL) clones.

Bernhard H, Karbach J, Wölfel T, Busch P, Störkel S, Stöckle M, Wölfel C, Seliger B, Huber C, Meyer zum Büschenfelde KH, et al. Bernhard H, et al. Among authors: seliger b. Int J Cancer. 1994 Dec 15;59(6):837-42. doi: 10.1002/ijc.2910590621. Int J Cancer. 1994. PMID: 7989126

3

Bipartite regulation of different components of the MHC class I antigen-processing machinery during dendritic cell maturation.

Li J, Schuler-Thurner B, Schuler G, Huber C, Seliger B. Li J, et al. Among authors: seliger b. Int Immunol. 2001 Dec;13(12):1515-23. doi: 10.1093/intimm/13.12.1515. Int Immunol. 2001. PMID: 11717192

4

Characterization of the major histocompatibility complex class I deficiencies in B16 melanoma cells.

Seliger B, Wollscheid U, Momburg F, Blankenstein T, Huber C. Seliger B, et al. Cancer Res. 2001 Feb 1;61(3):1095-9. Cancer Res. 2001. PMID: 11221838

5

HER-2/neu is expressed in human renal cell carcinoma at heterogeneous levels independently of tumor grading and staging and can be recognized by HLA-A2.1-restricted cytotoxic T lymphocytes.

Seliger B, Rongcun Y, Atkins D, Hammers S, Huber C, Störkel S, Kiessling R. Seliger B, et al. Int J Cancer. 2000 Aug 1;87(3):349-59. Int J Cancer. 2000. PMID: 10897039

6

Gene transfer of the Co-stimulatory molecules B7-1 and B7-2 enhances the immunogenicity of human renal cell carcinoma to a different extent.

Jung D, Hilmes C, Knuth A, Jaeger E, Huber C, Seliger B. Jung D, et al. Among authors: seliger b. Scand J Immunol. 1999 Sep;50(3):242-9. doi: 10.1046/j.1365-3083.1999.00588.x. Scand J Immunol. 1999. PMID: 10447932

7

Induction of immunogenicity of a human renal-cell carcinoma cell line by TAP1-gene transfer.

Kallfelz M, Jung D, Hilmes C, Knuth A, Jaeger E, Huber C, Seliger B. Kallfelz M, et al. Among authors: seliger b. Int J Cancer. 1999 Mar 31;81(1):125-33. doi: 10.1002/(sici)1097-0215(19990331)81:1<125::aid-ijc21>3.0.co;2-2. Int J Cancer. 1999. PMID: 10077163

8

Reduced membrane major histocompatibility complex class I density and stability in a subset of human renal cell carcinomas with low TAP and LMP expression.

Seliger B, Höhne A, Knuth A, Bernhard H, Ehring B, Tampé R, Huber C. Seliger B, et al. Clin Cancer Res. 1996 Aug;2(8):1427-33. Clin Cancer Res. 1996. PMID: 9816317

9

IFN-gamma-mediated coordinated transcriptional regulation of the human TAP-1 and LMP-2 genes in human renal cell carcinoma.

Seliger B, Hammers S, Höhne A, Zeidler R, Knuth A, Gerharz CD, Huber C. Seliger B, et al. Clin Cancer Res. 1997 Apr;3(4):573-8. Clin Cancer Res. 1997. PMID: 9815722

10

Heterogeneous expression of the tumor-associated antigens RAGE-1, PRAME, and glycoprotein 75 in human renal cell carcinoma: candidates for T-cell-based immunotherapies?

Neumann E, Engelsberg A, Decker J, Störkel S, Jaeger E, Huber C, Seliger B. Neumann E, et al. Among authors: seliger b. Cancer Res. 1998 Sep 15;58(18):4090-5. Cancer Res. 1998. PMID: 9751617

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results